Advertisement
Screener

BioTelemetry, Inc. Forms 3, 4 and 5: Stock Options, 2020

BioTelemetry, Inc. Forms 3, 4 and 5: Stock Options

Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 7 rows in 2020. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.

  • 2020-04-06: Reporting owner Stoica Andrei G; Form 4; Security Stock Options (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
  • 2020-02-18: Reporting owner Wisniewski Daniel; Form 4; Security Stock Options (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
  • 2020-02-18: Reporting owner Wadhwa Manish; Form 4; Security Stock Options (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
  • 2020-02-18: Reporting owner Broadway Fred; Form 4; Security Stock Options (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
Transaction dateReporting ownerFormSecurityTransactionSharesPricePrice that dayFiling
2020-04-06Stoica Andrei G
Officer (SVP & CTO)
4Stock Options (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+50,000
50,000 owned after
$39.73
exercise price
2020-04-08
2020-02-18Wisniewski Daniel
Officer (SVP, Technical Operations)
4Stock Options (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+4,188
4,188 owned after
$53.22
exercise price
2020-02-20
2020-02-18Wadhwa Manish
Officer (SVP & CMO)
4Stock Options (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+4,176
4,176 owned after
$53.22
exercise price
2020-02-20
2020-02-18Broadway Fred
Officer (President BioTel Heart)
4Stock Options (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+9,369
9,369 owned after
$53.22
exercise price
2020-02-20
2020-02-18Getz Heather C
Officer (EVP, CFO & CAO)
4Stock Options (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+10,635
10,635 owned after
$53.22
exercise price
2020-02-20
2020-02-18Capper Joseph H
Director, Officer (President & CEO)
4Stock Options (Right to Buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+42,291
42,291 owned after
$53.22
exercise price
2020-02-20
2020-01-10
holding as of filing
Wadhwa Manish
Officer (SVP & CMO)
3Stock Options (Right to Buy)
Derivative · Direct
Holding$73.27
exercise price
2020-01-10